VPRO — Viropro Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Viropro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2007 November 30th	2008 November 30th	2009 November 30th	2010 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Net Income/Starting Line	-2.65	-1.74	-1.46	-1.01
Depreciation
Non-Cash Items	1.55	0.964	0.625	0.123
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.266	-0.164	0.061	0.184
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-0.726	-0.873	-0.723	-0.676
Capital Expenditures	0	-0.073	-0.002	0
Purchase of Fixed Assets
Other Investing Cash Flow Items	0	0.048	0.003	0
Sale of Fixed Assets
Change in Net Investments
Cash from Investing Activities	0	-0.025	0.001	0
Financing Cash Flow Items	0.03	-0.043	0.12	0.17
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.726	0.893	0.79	0.263
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.057	-0.038	0.052	0.04